Message below is a paid advertisement. Content is provided by the sponsor.
 
Theodore J. Chiacchio, Esq. – Registered Patent Attorney
 
Patent law expert that you can trust will provide highly competent service in a cost-effective manner.
 
I partner with my clients to provide easy-to-understand, practical answers and strategy in a cost-effective manner. If there is a matter that could benefit from patent law expertise tailored to the pharmaceutical arts, I would be happy to discuss the matter with you.  
 
Over 15 years practicing patent law (approximately 95% of that experience has come while serving clients in the pharmaceutical industry).
Extensive experience on both the brand/NDA side and the generic/ANDA side.
Have prepared dozens of Opinions of Counsel and have spent over a decade representing pharmaceutical companies in connection with Hatch-Waxman and other patent infringement litigation.
Representative clients include GlaxoSmithKline, Daiichi-Sankyo, Mylan Pharmaceuticals, Lupin Pharmaceuticals, Apotex Inc., Baxalta, Catalent, Alembic Pharmaceuticals, Aurobindo Pharma, and Perrigo Company.
Representative matters have concerned the following drugs (among others): darunavir (Prezista®), capecitabine (Xeloda®), ranolazine (Ranexa®), guaifenesin (Mucinex®), mometasone furoate (Nasonex®), bimatoprost (Lumigan® .01%), ondansetron (Zofran®), ofloxacin (Floxin Otic®), levetiracetam (Keppra®), carbamazepine (Carbatrol®), nisoldipine (Sular®), pantoprazole (Protonix®), doxercalciferol (Hectorol®), paricalcitol (Zemplar®), fenofibrate (Tricor®), escitalopram (Lexapro®), desloratadine (Clarinex®), ibandronate (Boniva®), rosuvastatin calcium (Crestor®), PEGylated rFVIII (Adynovate®), atorvastatin calcium (Lipitor®), lamivudine/zidovudine (Combivir®), memantine (Namenda®), bupropion HCl (Welbutrin®), budesonide inhalation suspension (Pulmicort Respules®), and cefuroxime axetil (Ceftin®).
 
 
Theodore J. Chiacchio
Partner, SpencePC
405 N. Wabash Avenue, Suite P2E
Chicago, Illinois 60611
Email: ted.chiacchio@spencepc.com
Phone: (312) 635-5511
 
 
 
You received this email because you are a customer of PHE, a UBM publication. You are on the mailing list as %%emailaddress%%.